Strides gets USFDA popularity of Ursodiol Capsules

Strides gets USFDA popularity of Ursodiol Capsules

by admin- Monday, January 25th, 2021 04:19:04 PM

Strides Pharma Science introduced that its step-down absolutely owned subsidiary, Strides Pharma Global Pte. Ltd, Singapore, has acquired approval for Ursodiol Capsules USP, three hundred mg from the USA Food & Drug Administration (USFDA). The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug
(RLD), Actigall® Capsules, 300 mg, of Allergan Sales, LLC.

News Updates